Showing results (41-50 of 53) with videos related to
Sort By:
Pageof 6
Molecular Therapy. Advances|May 20, 2026
Sinbaglustat is efficacious in GM2 gangliosidosis primarily through inhibition of GBA2 rather than GCSMichel A Steiner, Catherine Vaillant, Marco Garzotti, et al.Psychoneuroendocrinology|March 22, 2017
BXD recombinant inbred strains participate in social preference, anxiety and depression behaviors along sex-differences in cytokines and tactile allodyniaCaridad López-Granero, Alessandra Antunes Dos Santos, Beatriz Ferrer, et al.Frontiers in Immunology|October 16, 2018
Neuropsychiatric Systemic Lupus Erythematosus Is Dependent on Sphingosine-1-Phosphate SignalingElise V Mike, Hadijat M Makinde, Evan Der, et al.Proceedings of the National Academy of Sciences of the United States of America|May 4, 2016
Selective expression of mutant huntingtin during development recapitulates characteristic features of Huntington's diseaseAldrin E Molero, Eduardo E Arteaga-Bracho, Christopher H Chen, et al.Behavioural Brain Research|October 4, 2008
Validation of a 2-day water maze protocol in miceMaria Gulinello, Michael Gertner, Guadalupe Mendoza, et al.Geroscience|July 7, 2022
Evidence for preserved insulin responsiveness in the aging rat brainMatthew G Engel, Jeremy Smith, Kai Mao, et al.Proceedings of the National Academy of Sciences of the United States of America|February 4, 2015
Rescue of homeostatic regulation of striatal excitability and locomotor activity in a mouse model of Huntington's diseaseYumei Cao, David Bartolomé-Martín, Naama Rotem, et al.Brain : a Journal of Neurology|October 4, 2011
X-linked Angelman-like syndrome caused by Slc9a6 knockout in mice exhibits evidence of endosomal-lysosomal dysfunctionPetter Strømme, Kostantin Dobrenis, Roy V Sillitoe, et al.Journal of Autoimmunity|April 26, 2015
TNF-like weak inducer of apoptosis promotes blood brain barrier disruption and increases neuronal cell death in MRL/lpr miceJing Wen, Jessica Doerner, Karen Weidenheim, et al.Journal of Autoimmunity|September 4, 2018
Lipocalin-2 is a pathogenic determinant and biomarker of neuropsychiatric lupusElise V Mike, Hadijat M Makinde, Maria Gulinello, et al.Pageof 6